Term ends Jun 23, 2037 · Medium confidence
20-year base term ends Jun 23, 2037
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,697,826), so the cap could be lower.
Jun 23, 2017
Jun 23, 2037
Aug 9, 2022
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 23, 2017, when application 15/632,001, the earliest non-provisional in its chain, was filed (this one was filed Jan 29, 2022) | Jun 23, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,337,028, US 11,697,826, US 9,982,279) | resolves to Jun 23, 2037, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 23, 2037 | Medium confidence |
This family
| US 9,982,279 | In force Jun 2037 | Jun 2037 |
| US 10,337,028 | In force Jun 2037 | Jun 2037 |
| US 11,697,826 | In force no later than Apr 2040 | no later than Apr 2040 |
| US 11,408,012 | this patent Jun 2037 | Jun 2037 |
| US 12,180,502 | In force no later than Jun 2037 | no later than Jun 2037 |
| Application 18/953,294 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 29, 2022 Reel 58902, frame 731 | Garst, Andrew; Gill, Ryan T.; Warnecke Lipscomb, Tanya Elizabeth | Muse Biotechnology, Inc. | Assignment of Assignor's Interest |
| Jan 29, 2022 Reel 58902, frame 738 | Muse Biotechnology, Inc. | Inscripta, Inc. | Change of Name |
| Sep 8, 2025 Reel 72836, frame 255 | Manus Bio Inc.; Sto.Peru I LLC; Sto.Peru II LLC; Manus Intermediate Inc.; Manus Inscripta, Inc. | Symbiotic Capital Agency LLC, as Administrative and Collateral Agent | Security Interest |
| Sep 15, 2025 Reel 72252, frame 203 | Inscripta, Inc.,; Manus Inscripta, Inc. | Manus Inscripta, Inc. | Merger and Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,337,028, US 11,697,826, US 9,982,279, ends no earlier than this term, so it caps nothing.